These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 17087059

  • 1. [Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: epidemiology, clinical pictures, and treatment].
    Borisevich IV, Markin VA, Firsova IV, Evseev AA, Khamitov RA, Maksimov VA.
    Vopr Virusol; 2006; 51(5):8-16. PubMed ID: 17087059
    [Abstract] [Full Text] [Related]

  • 2. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.
    Ivanoff B, Duquesnoy P, Languillat G, Saluzzo JF, Georges A, Gonzalez JP, McCormick J.
    Trans R Soc Trop Med Hyg; 1982; 76(6):719-20. PubMed ID: 7164137
    [Abstract] [Full Text] [Related]

  • 3. [Research with the Marburg, Lassa and Ebola viruses].
    Pshenichnov VA, Makhlaĭ AA, Mikhaĭlov VV.
    Vopr Virusol; 1993; 38(2):54-8. PubMed ID: 8059520
    [No Abstract] [Full Text] [Related]

  • 4. [Viral hemorrhagic fevers--Ebola hemorrhagic fever, Marburg virus disease, and Lassa fever].
    Taniguchi K.
    Nihon Naika Gakkai Zasshi; 2004 Nov 10; 93(11):2303-8. PubMed ID: 15624463
    [No Abstract] [Full Text] [Related]

  • 5. [Method for the simultaneous detection of immunofluorescing antibodies to the causative agents of different hemorrhagic fevers].
    Lukashevich IS, van der Groen G.
    Vopr Virusol; 1985 Nov 10; 30(5):624-6. PubMed ID: 3907144
    [No Abstract] [Full Text] [Related]

  • 6. The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses.
    Mattiuzzo G, Bentley EM, Page M.
    Viruses; 2019 Aug 24; 11(9):. PubMed ID: 31450611
    [Abstract] [Full Text] [Related]

  • 7. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.
    Johnson KM, Elliott LH, Heymann DL.
    J Clin Microbiol; 1981 Nov 24; 14(5):527-9. PubMed ID: 7031084
    [Abstract] [Full Text] [Related]

  • 8. Antibodies against haemorrhagic fever viruses in Kenya populations.
    Johnson BK, Ocheng D, Gichogo A, Okiro M, Libondo D, Tukei PM, Ho M, Mugambi M, Timms GL, French M.
    Trans R Soc Trop Med Hyg; 1983 Nov 24; 77(5):731-3. PubMed ID: 6419422
    [Abstract] [Full Text] [Related]

  • 9. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay.
    Van der Groen G, Elliot LH.
    Ann Soc Belg Med Trop; 1982 Mar 24; 62(1):49-54. PubMed ID: 7049096
    [No Abstract] [Full Text] [Related]

  • 10. Emerging diseases. On the trail of Ebola and Marburg viruses.
    Balter M.
    Science; 2000 Nov 03; 290(5493):923-5. PubMed ID: 11184732
    [No Abstract] [Full Text] [Related]

  • 11. [Marburg and Ebola hemorrhagic fevers--pathogens, epidemiology and therapy].
    Stock I.
    Med Monatsschr Pharm; 2014 Sep 03; 37(9):324-30; quiz 331-2. PubMed ID: 25282746
    [Abstract] [Full Text] [Related]

  • 12. Multivalent DNA Vaccines as A Strategy to Combat Multiple Concurrent Epidemics: Mosquito-Borne and Hemorrhagic Fever Viruses.
    Jiang J, Ramos SJ, Bangalore P, Elwood D, Cashman KA, Kudchodkar SB, Schultheis K, Pugh H, Walters J, Tur J, Yan J, Patel A, Muthumani K, Schmaljohn CS, Weiner DB, Humeau LM, Broderick KE.
    Viruses; 2021 Feb 27; 13(3):. PubMed ID: 33673603
    [Abstract] [Full Text] [Related]

  • 13. Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps.
    Kerber R, Reindl S, Romanowski V, Gómez RM, Ogbaini-Emovon E, Günther S, ter Meulen J.
    J Clin Virol; 2015 Mar 27; 64():120-7. PubMed ID: 25549822
    [Abstract] [Full Text] [Related]

  • 14. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
    Grant-Klein RJ, Altamura LA, Schmaljohn CS.
    Virus Res; 2011 Dec 27; 162(1-2):148-61. PubMed ID: 21925552
    [Abstract] [Full Text] [Related]

  • 15. [Viral hemorrhagic fever--Ebola hemorrhagic fever, Marburg disease and Lassa fever].
    Hotta H.
    Rinsho Byori; 1998 Jul 27; 46(7):651-5. PubMed ID: 9721531
    [Abstract] [Full Text] [Related]

  • 16. Epidemiology. Emerging disease or diagnosis?
    Gire SK, Stremlau M, Andersen KG, Schaffner SF, Bjornson Z, Rubins K, Hensley L, McCormick JB, Lander ES, Garry RF, Happi C, Sabeti PC.
    Science; 2012 Nov 09; 338(6108):750-2. PubMed ID: 23139320
    [No Abstract] [Full Text] [Related]

  • 17. [Indirect immunoenzyme method for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers].
    Ivanov AP, Tkachenko EA, van der Groen G, Butenko AM, Konstantinov OK.
    Vopr Virusol; 1986 Nov 09; 31(2):186-90. PubMed ID: 3524001
    [Abstract] [Full Text] [Related]

  • 18. Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses.
    Curtis N.
    Adv Exp Med Biol; 2006 Nov 09; 582():35-44. PubMed ID: 16802617
    [No Abstract] [Full Text] [Related]

  • 19. Machupo Virus Expressing GPC of the Candid#1 Vaccine Strain of Junin Virus Is Highly Attenuated and Immunogenic.
    Koma T, Patterson M, Huang C, Seregin AV, Maharaj PD, Miller M, Smith JN, Walker AG, Hallam S, Paessler S.
    J Virol; 2016 Feb 01; 90(3):1290-7. PubMed ID: 26581982
    [Abstract] [Full Text] [Related]

  • 20. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
    Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR.
    J Pathol; 2015 Jan 01; 235(2):153-74. PubMed ID: 25297522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.